Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on The Bookshelf Times.
Dennis R. Garcia’s Latest Book, Las Madres, Acclaimed at 2025 International Latino Book Awards
SAN DIEGO, CA, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- Las Madres: Latinas in the Heartland Who Led Their Family to Success, a 2025 Kansas Notable Book, received three awards from the International Latino Book Awards (ILBA), the...
R.J. Halbert's Caretaker Awarded the 2025 Silver Bill Fisher Award and Gold American Legacy Book Awards
A spellbinding supernatural story that’s winning over readers, book clubs, and reviewers NASHVILLE, TN, UNITED STATES, October 25, 2025 /EINPresswire.com/ -- R.J. Halbert’s debut novel, Caretaker: Book One of The Goodpasture Chronicles, has been...
Amphista Therapeutics’ successful degradation of a key cancer target, BRD9, via a novel mechanism with DCAF16 E3 ligase published in Nature Communications
The publication reports the highly selective, DCAF16 E3 enabled degradation of BRD9 in vivo using Amphista’s proprietary, next generation Targeted Glue™ medicinal chemistry technology Amphista’s scientists prospectively and rationally designed...
Madrigal Pharmaceuticals Reports Third-Quarter 2025 Financial Results and Provides Corporate Updates
Third-quarter 2025 Rezdiffra™ (resmetirom) net sales of $287.3 million As of September 30, 2025, more than 29,500 patients on Rezdiffra Closed global licensing agreement with CSPC Pharma to add oral GLP-1 to pipeline New Orange Book listed patent...
New Book Calls for Radical Rethinking of American Society, Lays Out Blueprint for 'New Republic'
WE, THE LEARNERS: Knowing, Learning, and Participating in a New Republic by William F. Brazier FAIRFAX COUNTY, VA, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- As civic unrest and political polarization continue to dominate public...
PSB Holdings, Inc. Reports Quarterly Earnings of $0.86 Per Share; Net Interest Margin and Tangible Net Book Value Expansion Continues
WAUSAU, Wis., Oct. 27, 2025 (GLOBE NEWSWIRE) -- PSB Holdings, Inc. (“PSB”) (OTCQX: PSBQ), the holding company for Peoples State Bank (“Peoples”) serving Northcentral and Southeastern Wisconsin reported third quarter earnings ending September 30,...
Using Machine Learning (AI) in Road Safety Research
4 November 2025, Geneva, Switzerland - Road traffic fatalities remain a critical global challenge, with young people being disproportionately affected. Drink-driving, or Driving Under the Influence (DUI), is a major contributor to these...
Owner: United Nations
Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ Rejection
Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first half of 2026 Novel immunomodulatory regimen designed to reduce calcineurin inhibitor exposure and improve...
Levicept Presents New Data Suggesting a Novel Neurotrophin-3 Inhibitor, LEVI-04, May Modify Disease and Improve Symptoms in Osteoarthritis
In a Phase II trial, LEVI-04 demonstrated a significant, dose-dependent reduction in bone marrow lesions (BML) compared with placebo in patients with osteoarthritis (OA) A significant correlation between improvements in OA symptoms and positive...
White Paper Published on HER2-Low Breast Cancer: the Case for Molecular Diagnostics
BERLIN, GERMANY, October 27, 2025 /EINPresswire.com/ -- Cerca Biotech., a German-based diagnostics company, announces the publication of a white paper highlighting the importance of molecular diagnostics in HER2-low breast cancer cases as a...
Health Canada Grants Authorization for “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease
TOKYO and CAMBRIDGE, Mass., Oct. 26, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher,...
Plastics Trade and Waste Outlook, Rising Exports, Mounting Environmental Challenges (1950-2050)
Ottawa, Nov. 04, 2025 (GLOBE NEWSWIRE) -- According to Towards Packaging, a sister firm of Precedence Research, global plastics production and trade have expanded dramatically over the past decades, with countries such as the U.S., China, Germany,...
Author Aurealia Nelson Reclaims the 'Bad Witch' Archetype in New Book 'How To Be A Bad Witch'
A modern guide to transforming an ancient insult into your greatest source of power. NEW YORK, NY, UNITED STATES, October 22, 2025 /EINPresswire.com/ -- For every woman who has ever been told she is “too loud,” “too opinionated,” or “too much,”...
Writer-in-Residence by J.A. Hoskins — A Compelling Debut Novel of Loss, Rediscovery, and Second Chances
A story that stays with you — beautifully written and full of hope. It will leave you feeling that anything is possible. SUNSHINE COAST, QUEENSLAND, AUSTRALIA, October 21, 2025 /EINPresswire.com/ -- Australian author J.A. Hoskins has released...
Talkadot Named Exclusive Speaker Booking Partner for Destination Michigan
Event planners now have a faster, data-driven way to discover and book proven professional speakers while helping speakers generate repeat bookings. LAS VEGAS, NV, UNITED STATES, November 3, 2025 /EINPresswire.com/ -- Talkadot, the speaker...
Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531
– Mean weight loss of 19.2%I at 6 mg with no plateau and favorable safety profile in 48-week Phase 3 clinical trial – – Data builds on previously reported Phase 2 results that showed mean weight loss of 23.6%I at 8 mg at week 36 with no plateau –...
Aardvark Therapeutics Presents Data Supporting its Metabolic Obesity Pipeline Programs at ObesityWeek 2025
New preclinical results demonstrate the potential of ARD-201 in enhanced glucose control, along with preservation of lean mass, underscoring its opportunity in addressing key challenges in today’s obesity treatment landscape Preclinical and...
Transgene Provides Business and Financial Update for Q3 2025
Comprehensive immunogenicity data of individualized neoantigen therapeutic vaccine (INTV) TG4050, from the randomized Phase I study in operable Head and Neck Squamous Cell Carcinoma (HNSCC) patients, to be presented at SITC 2025 New TG4050 data...
Author and homebuilding expert David Herzog’s new book, From Vision to Completion, achieves Best Seller status
HOUSTON, TX, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- From Vision to Completion, published by Game Changer Publishing, offers a practical overview of how homes and other built projects progress from an initial idea to a finished...
New Phase I Immunological Data Presented at SITC 2025 Support TG4050’s Potential Role in Preventing Cancer Relapse
New data provide key mechanistic insights into how TG4050 induces and sustains potent, CD8+ T cell responses in operable HNSCC[*] patients Comprehensive immunogenicity data demonstrate TG4050’s ability to induce neoantigen-specific cytotoxic CD8+...